Get the Stockscreener App
0.92
2.54%
-0.01
Nanovibronix Inc stock is traded at $0.92, with a volume of 429.93K.
It is down -2.54% in the last 24 hours and up +0.71% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
See More
Previous Close:
$0.93
Open:
$0.9344
24h Volume:
429.93K
Relative Volume:
0.09
Market Cap:
$2.10M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
-0.748
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-2.24%
1M Performance:
+0.71%
6M Performance:
-85.59%
1Y Performance:
-88.56%
1-Day Range:
$0.9005
$0.935
1-Week Range:
$0.90
$0.975
52-Week Range:
$0.6669
$16.10
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.9199 | 2.10M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
133.09 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.48 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.07 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.45 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.61 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Nanovibronix Inc Stock (NAOV) Latest News
NAOV’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
3 Penny Stocks to Watch Now, 6/12/25 - TipRanks
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Gui - GuruFocus
NanoVibronix (NAOV) Secures U.S. Patent for Pediatric Feeding Tu - GuruFocus
NanoVibronix receives U.S. patent for pediatric feeding tube system By Investing.com - Investing.com Canada
NanoVibronix Stock Soars: Why This Tiny Medical Tech Is Making Big Waves Today - RagingBull
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
NanoVibronix receives U.S. patent for pediatric feeding tube system - Investing.com
Revolutionary Patent: ENvue Medical Targets 1.5M Annual Pediatric Procedures with Smart Feeding Tube Technology - Stock Titan
NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’ - MSN
NanoVibronix appoints new CEO after acquisition By Investing.com - Investing.com India
NanoVibronix Appoints Doron Besser as New CEO - TipRanks
NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’ By Stocktwits - Investing.com India
NanoVibronix Appoints Doron Besser as CEO - citybiz
NanoVibronix, Inc Announces CEO Changes, Effective June 4, 2025 - marketscreener.com
NanoVibronix Has a Leadership Transition - Medical Product Outsourcing
NanoVibronix (NAOV) Appoints New CEO as Leadership Changes Unfol - GuruFocus
NanoVibronix appoints new CEO after acquisition - Investing.com Australia
NanoVibronix Announces CEO Transition | NAOV Stock News - GuruFocus
NanoVibronix Announces CEO Transition - Business Wire
NanoVibronix Shares Positive Results from UroShield Case Series - Medical Product Outsourcing
NanoVibronix refutes false stock offering claims By Investing.com - Investing.com South Africa
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
NanoVibronix says offering posts falsely issued by Flash Alert, FintelAlerts - TipRanks
NanoVibronix (NAOV) Denies $26M Stock Offering Rumors | NAOV Sto - GuruFocus
NanoVibronix Responds to False Post | NAOV Stock News - GuruFocus
NanoVibronix refutes false stock offering claims - Investing.com
NanoVibronix Responds to False Post - marketscreener.com
NanoVibronix Exposes False $26M Stock Offering Alert: Company Takes Action Against Misinformation - Stock Titan
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures | NAOV Stock News - GuruFocus
Major Louisiana Hospital Ditches Blind Insertions for Advanced ENvue Feeding Tube Technology - Stock Titan
Major Louisiana Hospital Selects ENvue System for Feeding Tube P - GuruFocus
NanoVibronix stock plunges to 52-week low at $1.14 By Investing.com - Investing.com South Africa
NanoVibronix stock plunges to 52-week low at $1.14 - Investing.com
NanoVibronix, Inc. SEC 10-Q Report - TradingView
NanoVibronix announces pricing of public offering - Medical Buyer
NanoVibronix announces pricing of $10 million public offering - MSN
NanoVibronix Announces Closing Of $10 Million Public Offering Of Preferred Stock And Warrants - marketscreener.com
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants - Business Wire
NanoVibronix (NAOV) Announces $10 Million Public Offering - GuruFocus
SEC Form 424B4 filed by NanoVibronix Inc. - Quantisnow
Nasdaq Top 5 Premarket Losers: Healthcare Triangle, Klotho Neurosciences, New Fortress Energy, NanoVibronix, MDJM - MSN
NanoVibronix sets terms for $10 million public offering By Investing.com - Investing.com Nigeria
NanoVibronix acquires enteral tech firm ENvue Medical - MSN
NanoVibronix Delays Q1 2025 Financial Report - TipRanks
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants | NAOV Stock News - GuruFocus
NanoVibronix sets terms for $10 million public offering - Investing.com
NanoVibronix Secures $10M Through Preferred Stock Sale: Strategic Move to Eliminate $2M in Recent Debt - Stock Titan
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):